Gavin Wood insider trades

Open-market stock purchases and sales by Gavin Wood, Chief Financial Officer at Adaptimmune Therapeutics plc, from SEC Form 4 filings since Jul 26, 2013.

Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -90%.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • ADAP Adaptimmune Therapeutics plc: 3 buys, 1 sale, last Sep 2, 2025
  • AFFX Affymetrix Inc: 4 sales, last Mar 31, 2016
  • AF Affymetrix Inc: other filings, last Nov 17, 2014

Get free alerts when Gavin Wood files a new trade →